{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T11:21:17Z","timestamp":1793532077475,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1016\/j.vaccine.2008.12.041","type":"journal-article","created":{"date-parts":[[2009,1,14]],"date-time":"2009-01-14T09:23:41Z","timestamp":1231925021000},"page":"1386-1392","source":"Crossref","is-referenced-by-count":32,"title":["Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1\/O139 whole cell cholera vaccine: Comparison with other mucosal and systemic responses"],"prefix":"10.1016","volume":"27","author":[{"given":"Sohel","family":"Shamsuzzaman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanvir","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiissar","family":"Mannoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin Ara","family":"Begum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradip Kumar","family":"Bardhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Bradley","family":"Sack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Sack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Mari","family":"Svennerholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Holmgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firdausi","family":"Qadri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.vaccine.2008.12.041_bib1","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.vaccine.2006.09.049","article-title":"Safety and immunogenicity of a reformulated Vietnamese bivalent killed, whole-cell, oral cholera vaccine in adults","volume":"25","author":"Anh","year":"2007","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2008.12.041_bib2","first-page":"2","article-title":"Investigations into the safety and immunogenicity of a killed oral cholera vaccine developed in Viet Nam","volume":"80","author":"Trach","year":"2002","journal-title":"Bull World Health Organ"},{"issue":"4","key":"10.1016\/j.vaccine.2008.12.041_bib3","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/ije\/22.4.724","article-title":"The design and analysis of cholera vaccine trials: recent lessons from Bangladesh","volume":"22","author":"Clemens","year":"1993","journal-title":"Int J Epidemiol"},{"issue":"13","key":"10.1016\/j.vaccine.2008.12.041_bib4","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/0264-410X(92)90324-D","article-title":"An oral B subunit: whole cell vaccine against cholera","volume":"10","author":"Holmgren","year":"1992","journal-title":"Vaccine"},{"issue":"15","key":"10.1016\/j.vaccine.2008.12.041_bib5","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0264-410X(96)00071-0","article-title":"Intestinal and systemic immune responses in humans after oral immunization with a bivalent B subunit-O1\/O139 whole cell cholera vaccine","volume":"14","author":"Jertborn","year":"1996","journal-title":"Vaccine"},{"issue":"20","key":"10.1016\/j.vaccine.2008.12.041_bib6","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1016\/j.vaccine.2006.03.008","article-title":"Long-term effectiveness against cholera of oral killed whole-cell vaccine produced in Vietnam","volume":"24","author":"Thiem","year":"2006","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2008.12.041_bib7","doi-asserted-by":"crossref","first-page":"e2323","DOI":"10.1371\/journal.pone.0002323","article-title":"A randomized, placebo-controlled trial of the bivalent killed, whole-cell, oral cholera vaccine in adults and children in a cholera endemic area in Kolkata, India","volume":"3","author":"Mahalanabis","year":"2008","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.vaccine.2008.12.041_bib8","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1586\/14760584.7.5.561","article-title":"Vaccination with Dukoral against travelers\u2019 diarrhea (ETEC) and cholera","volume":"7","author":"Jelinek","year":"2008","journal-title":"Expert Rev Vaccines"},{"issue":"2","key":"10.1016\/j.vaccine.2008.12.041_bib9","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/0264-410X(92)90030-N","article-title":"Safety and immunogenicity of an oral recombinant cholera B subunit-whole cell vaccine in Swedish volunteers","volume":"10","author":"Jertborn","year":"1992","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2008.12.041_bib10","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/0264-410X(93)90125-H","article-title":"Evaluation of different immunization schedules for oral cholera B subunit-whole cell vaccine in Swedish volunteers","volume":"11","author":"Jertborn","year":"1993","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2008.12.041_bib11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/infdis\/155.1.79","article-title":"B subunit-whole cell and whole cell-only oral vaccines against cholera: studies on reactogenicity and immunogenicity","volume":"155","author":"Clemens","year":"1987","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2008.12.041_bib12","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/0264-410X(93)90380-G","article-title":"Intestinal antibody response after oral immunization with a prototype cholera B subunit-colonization factor antigen enterotoxigenic Escherichia coli vaccine","volume":"11","author":"Ahren","year":"1993","journal-title":"Vaccine"},{"issue":"19\u201320","key":"10.1016\/j.vaccine.2008.12.041_bib13","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1016\/S0264-410X(03)00077-X","article-title":"Safety and immunogenicity of an oral, inactivated enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Bangladeshi children 18\u201336 months of age","volume":"21","author":"Qadri","year":"2003","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2008.12.041_bib14","doi-asserted-by":"crossref","first-page":"6234","DOI":"10.1128\/IAI.67.12.6234-6241.1999","article-title":"Intestinal immune responses in patients infected with enterotoxigenic Escherichia coli and in vaccinees","volume":"67","author":"Wenneras","year":"1999","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2008.12.041_bib15","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1128\/CDLI.6.6.812-818.1999","article-title":"Lipopolysaccharide- and cholera toxin-specific subclass distribution of B-cell responses in cholera","volume":"6","author":"Qadri","year":"1999","journal-title":"Clin Diagn Lab Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2008.12.041_bib16","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1128\/JCM.17.4.596-600.1983","article-title":"Rapid GM1-enzyme-linked immunosorbent assay with visual reading for identification of Escherichia coli heat-labile enterotoxin","volume":"17","author":"Svennerholm","year":"1983","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.12.041_bib17","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1128\/JCM.24.2.203-209.1986","article-title":"Saliva, breast milk, and serum antibody responses as indirect measures of intestinal immunity after oral cholera vaccination or natural disease","volume":"24","author":"Jertborn","year":"1986","journal-title":"J Clin Microbiol"},{"issue":"10","key":"10.1016\/j.vaccine.2008.12.041_bib18","doi-asserted-by":"crossref","first-page":"6577","DOI":"10.1128\/IAI.73.10.6577-6583.2005","article-title":"Reduction in capsular content and enhanced bacterial susceptibility to serum killing of Vibrio cholerae O139 associated with the 2002 cholera epidemic in Bangladesh","volume":"73","author":"Qadri","year":"2005","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2008.12.041_bib19","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1128\/CDLI.2.6.685-688.1995","article-title":"Comparison of the vibriocidal antibody response in cholera due to Vibrio cholerae O139 Bengal with the response in cholera due to Vibrio cholerae O1","volume":"2","author":"Qadri","year":"1995","journal-title":"Clin Diagn Lab Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2008.12.041_bib20","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1128\/IAI.65.9.3571-3576.1997","article-title":"Comparison of immune responses in patients infected with Vibrio cholerae O139 and O1","volume":"65","author":"Qadri","year":"1997","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2008.12.041_bib21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0022-1759(88)90306-7","article-title":"A novel two colour ELISPOT assay. I. Simultaneous detection of distinct types of antibody-secreting cells","volume":"115","author":"Czerkinsky","year":"1988","journal-title":"J Immunol Methods"},{"issue":"8","key":"10.1016\/j.vaccine.2008.12.041_bib22","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1128\/IAI.71.8.4808-4814.2003","article-title":"Antigen-specific immunoglobulin A antibodies secreted from circulating B cells are an effective marker for recent local immune responses in patients with cholera: comparison to antibody-secreting cell responses and other immunological markers","volume":"71","author":"Qadri","year":"2003","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2008.12.041_bib23","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1086\/368132","article-title":"Supplementation with zinc, but not vitamin A, improves seroconversion to vibriocidal antibody in children given an oral cholera vaccine","volume":"187","author":"Albert","year":"2003","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2008.12.041_bib24","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1128\/IAI.60.7.2605-2611.1992","article-title":"Antibody-secreting cells in human peripheral blood after oral immunization with an inactivated enterotoxigenic Escherichia coli vaccine","volume":"60","author":"Wenneras","year":"1992","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2008.12.041_bib25","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1086\/515306","article-title":"Enteric infections in an endemic area induce a circulating antibody-secreting cell response with homing potentials to both mucosal and systemic tissues","volume":"177","author":"Qadri","year":"1998","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2008.12.041_bib26","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1128\/CDLI.4.3.264-269.1997","article-title":"Vibriocidal antibody responses in North American volunteers exposed to wild-type or vaccine Vibrio cholerae O139: specificity and relevance to immunity","volume":"4","author":"Losonsky","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"issue":"8499","key":"10.1016\/j.vaccine.2008.12.041_bib27","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0140-6736(86)91944-6","article-title":"Field trial of oral cholera vaccines in Bangladesh","volume":"2","author":"Clemens","year":"1986","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.vaccine.2008.12.041_bib28","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000233587","article-title":"Gut mucosal, salivary and serum antitoxic and antibacterial antibody responses in Swedes after oral immunization with B subunit-whole cell cholera vaccine","volume":"75","author":"Jertborn","year":"1984","journal-title":"Int Arch Allergy Appl Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2008.12.041_bib29","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1097\/INF.0b013e3181783adf","article-title":"A comparison of clinical and immunologic features in children and older patients hospitalized with severe cholera in Bangladesh","volume":"27","author":"Chowdhury","year":"2008","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"10.1016\/j.vaccine.2008.12.041_bib30","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1086\/432074","article-title":"Randomized, controlled study of the safety and immunogenicity of Peru-15, a live attenuated oral vaccine candidate for cholera, in adult volunteers in Bangladesh","volume":"192","author":"Qadri","year":"2005","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2008.12.041_bib31","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1073\/pnas.0337468100","article-title":"Emergence and evolution of Vibrio cholerae O139","volume":"100","author":"Faruque","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2008.12.041_bib32","first-page":"4","article-title":"Emerging & re-emerging bacterial pathogens in India","volume":"103","author":"John","year":"1996","journal-title":"Indian J Med Res"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08017696?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08017696?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T16:28:27Z","timestamp":1589473707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08017696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S0264410X08017696"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.12.041","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}